Moving forward in bladder cancer detection and diagnosis: the role of epigenetic biomarkers. (Q38068225)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23249204%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

review article

1 reference

title

Moving forward in bladder cancer detection and diagnosis: the role of epigenetic biomarkers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23249204%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23249204%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Carmen Jeronimo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23249204%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Rui Henrique

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23249204%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Ana Isabel Oliveira

1

1 reference

28 August 2017

Carmen Jerónimo

2

1 reference

28 August 2017

Rui Henrique

3

1 reference

28 August 2017

publication date

1 November 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23249204%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

20 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23249204%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23249204%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23249204%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

871-878

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23249204%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

cites work

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

The effect of age and gender on bladder cancer: a critical review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Molecular pathogenesis and diagnostics of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Molecular biomarkers for urothelial carcinoma of the bladder: challenges in clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Molecular alterations associated with bladder cancer initiation and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Bladder cancer: translating molecular genetic insights into clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Molecular pathogenesis of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Cancer epigenetics reaches mainstream oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

21 January 2018

Epigenetics in cancer

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Epigenetic biomarkers for human cancer: the time is now.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Histone onco-modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Roles of small RNAs in tumor formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Global epigenetic profiling in bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Epigenetics in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Epigenetic biomarkers in urothelial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Interest of methylated genes as biomarkers in urothelial cell carcinomas of the urinary tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Hypermethylation in bladder cancer: biological pathways and translational applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Cancer epigenomics: DNA methylomes and histone-modification maps

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Genome-wide approaches to studying chromatin modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

The methylome: approaches for global DNA methylation profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Three epigenetic biomarkers, GDF15, TMEFF2, and VIM, accurately predict bladder cancer from DNA-based analyses of urine samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Potential new urinary markers in the early detection of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Identification and validation of the methylated TWIST1 and NID2 genes through real-time methylation-specific polymerase chain reaction assays for the noninvasive detection of primary bladder cancer in urine samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Custom-designed MLPA using multiple short synthetic probes: application to methylation analysis of five promoter CpG islands in tumor and urine specimens from patients with bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Multiplexed methylation profiles of tumor suppressor genes in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Distinct microRNA alterations characterize high- and low-grade bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Hypermethylation of cell-free serum DNA indicates worse outcome in patients with bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Carcinogen exposure and gene promoter hypermethylation in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Identification of PMF1 methylation in association with bladder cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

KISS1 methylation and expression as tumor stratification biomarkers and clinical outcome prognosticators for bladder cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Discovery of myopodin methylation in bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Molecular detection of noninvasive and invasive bladder tumor tissues and exfoliated cells by aberrant promoter methylation of laminin-5 encoding genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Prognostic value of opioid binding protein/cell adhesion molecule-like promoter methylation in bladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Promoter hypermethylation identifies progression risk in bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Identification of methylated genes associated with aggressive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Unique DNA methylation patterns distinguish noninvasive and invasive urothelial cancers and establish an epigenetic field defect in premalignant tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Phosphorylated H2AX in noninvasive low grade urothelial carcinoma of the bladder: correlation with tumor recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

A novel epigenetic phenotype associated with the most aggressive pathway of bladder tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Increased EZH2 protein expression is associated with invasive urothelial carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Expression of the polycomb group protein EZH2 and its relation to outcome in patients with urothelial carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

MiRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

Comprehensive Genome Methylation Analysis in Bladder Cancer: Identification and Validation of Novel Methylated Genes and Application of These as Urinary Tumor Markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERM.12.114

21 January 2018

Identifiers

DOI

10.1586/ERM.12.114

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23249204%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference